1-L Prep Boosts Quality, Not Adequacy - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

1-L Prep Boosts Quality, Not Adequacy

Randomized trial in hospitalized patients found improved high-quality bowel cleansing with 1-L regimen, though primary endpoint differences were not statistically significant

  • By

  • Andrea Surnit

  • May 5, 2026

  • 3 min

Share

Original Source(s)

1-L Prep Boosts Quality, Not Adequacy

  • by Andrea Surnit

  • May 5, 2026

Related Content

How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages

“There is incredible uncertainty in drug dosing.”

Social vulnerability may contribute to disparities in ovarian cancer survival

Neighborhood vulnerability was associated with poorer survival among women with epithelial ovarian cancer, with a stronger association among Black women.

FDA Monthly Preview: Key July Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.